MEDIBLOUX
ActiveThe computed 12-month bankruptcy probability of MEDIBLOUX is 1.9% (moderate). The 2024 annual accounts show equity of €37k and a net result of €44k. Equity is growing by ~57.5% per year across the filed fiscal years. Its solvency ranks better than 44% of 26051 sector peers (fiscal year 2024). The company has been active since 2018 and the Belgian State Gazette contains no insolvency or warning signals.
Checked score
Score 2024
73
/ 100
Healthy▲ +2 vs 2023
The score combines four axes. Every signal that weighs is under Signals.
Axes · tick = 2023
Profitability100=
Solvency45▲+10
Growth78=
Stability100
Bankruptcy probability, 12 months
1.9%
Moderate
0%0.5%1.5%4%10%≥ 25%
Credit up to €3k at 30 days acceptable
Liquidity tight (current ratio 1.32 against 1.22 in 2023), and 74.5% of the assets are financed with debt.
Credit advice for your own amount and term
Signals
Six signals. The signal on the left, the evidence on the right.
+raises risk○neutral
raises risk · Limited track record
This company has not been active as long as an established one and statistically fails somewhat more often.
KBO · incorporation dateAge against the risk zone
raises risk · Higher-failure-rate sector
In this sector companies fail more often than the Belgian average.
Gazette · bankruptcies per sector, NACE 47
Relative position
BE, all sectors
reference
Sector 47
higher
← fewer bankruptcies
more bankruptcies →
raises risk · Annual accounts: weaker financial profile
The latest annual accounts show a weaker profile in solvency, result or liquidity than companies that stay afloat.
NBB · annual accounts 2024Solvency, return and age of the figures
Solvency
25.5%
Return on assets
30.1%
Age of the figures
20 mo
neutral · Filed after the deadline
The financial year that closed on 31-12-2024 was due by 31-07-2025 and was filed on 31-08-2025, 31 days later. For context: 47% of the Belgian market files late and the whole 1-to-90-day band measures 2.0% abnormal legal state against a 1.66% average. We show this as a fact and do not score it.
NBB · 6 filingsDeviation from the deadline
2025
not confirmed
2024
31 d late
2023
118 d late
2022
153 d late
2021
153 d late
2020
100 d late
2019
63 d late
← before the deadline
after the deadline →
Financials · fiscal year 2024, micro schema
Equity
€37k▲ 26.4%
2023 · €29k
2019: €-13k
2020: €-24k
2021: €12k
2022: €13k
2023: €29k
2019 → 2024
Total assets
€145k▲ 9.4%
2023 · €133k
2019: €60k
2020: €61k
2021: €92k
2022: €109k
2023: €133k
2019 → 2024
Net result
€44k▼ 22.6%
2023 · €56k
2019: €-33k
2020: €-10k
2021: €35k
2022: €41k
2023: €56k
2019 → 2024
Working capital
€34k▲ 45.3%
2023 · €23k
2019: €11k
2020: €-6k
2021: €24k
2022: €9k
2023: €23k
2019 → 2024
Multi-year overview
Every figure with its change against the year before
▲ rise
▼ fall
Line20202021202220232024Trend
Equity€-24k-€12k€13k▲ 11.6%€29k▲ 127%€37k▲ 26.4%
Operating result€-9k-€39k€46k▲ 18.8%€68k▲ 47.1%€51k▼ 25.2%
Net result€-10k-€35k€41k▲ 17.5%€56k▲ 36.3%€44k▼ 22.6%
Turnover and EBIT margin not published: the micro schema does not require them.
Result per fiscal year
Operating resultNet result
The operating result falls in 2024; 2024 is 25% below 2023.
Balance-sheet composition
2024 in colour, 2023 as the grey bar beneath
Assets €145k
Fixed assets
€5k▼ 24.6%
Current assets
€140k▲ 11.0%
Equity and liabilities €145k
Equity
€37k▲ 26.4%
Debt
€108k▲ 4.5%
The debt ratio falls from 78.0% to 74.5%: equity grows faster than debt.
Key figures and ratios
EBITDA
€52k▼
2023 · €72k
Cash flow
€45k▼
2023 · €61k
Solvency
25.5%▲
2023 · 22.0%
Current ratio
1.32▲
2023 · 1.22
Quick ratio
0.92▲
2023 · 0.81
Debt / equity
2.93▼
2023 · 3.54
ROE
118.0%▼
2023 · 192.8%
ROA
30.1%▼
2023 · 42.5%
Interest coverage
9.64▼
2023 · 15.33
Debt
€108k▲
2023 · €103k
Debt ≤ 1 year
€107k▲
2023 · €103k
Debt > 1 year
€1k
Income taxes
€5k▼
2023 · €7k
Green means a favourable move, even when the figure itself falls: as with debt or debt / equity.
Filed annual accounts
As filed with the NBB · 2024 against 2023
Balance sheet
Code20232024
Assets
Total assets20/58€133k€145k▲
Fixed assets21/28€6k€5k▼
Tangible fixed assets22/27€6k€5k▼
Furniture and vehicles24€2k€2k▼
Leasing and similar rights25€4k€3k▼
Current assets29/58€127k€140k▲
Amounts receivable after more than one year29-€32k
Other amounts receivable291-€32k
Stocks and contracts in progress3€43k€42k▼
Stocks30/36€43k€42k▼
Amounts receivable within one year40/41€27k€28k▲
Trade receivables40€27k€25k▼
Other amounts receivable41-€4k
Cash at bank and in hand54/58€53k€30k▼
Deferred charges and accrued income490/1€3k€8k▲
Equity and liabilities
Total equity and liabilities10/49€133k€145k▲
Equity10/15€29k€37k▲
Contributions10/11€20k€20k=
Profit (loss) carried forward14€9k€17k▲
Amounts payable17/49€103k€108k▲
Amounts payable after more than one year17-€1k
Financial debts170/4-€1k
Amounts payable within one year42/48€103k€107k▲
Current portion of amounts payable after more than one year42€6k€8k▲
Financial debts43€1k€1k▼
Credit institutions430/8€1k€1k▼
Trade debts44€30k€28k▼
Suppliers440/4€30k€28k▼
Taxes, remuneration and social security45€21k€26k▲
Taxes450/3€17k€24k▲
Remuneration and social security454/9€5k€2k▼
Other amounts payable47/48€45k€44k▼
Income statement
Code20232024
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€4k€1k▼
Other operating charges640/8€2k€1k▼
Gross operating margin9900€75k€53k▼
Operating profit (loss)9901€68k€51k▼
Financial income75/76B€298€3k▲
Recurring financial income75€298€3k▲
Financial charges65/66B€5k€5k▲
Recurring financial charges65€5k€5k▲
Profit (loss) for the period before taxes9903€63k€49k▼
Income taxes67/77€7k€5k▼
Profit (loss) for the period9904€56k€44k▼
Profit (loss) for the period to be appropriated9905€56k€44k▼
Appropriation of the result
Profit (loss) to be appropriated9906€49k€53k▲
Profit (loss) brought forward from the previous period14P€-7k€9k▲
Profit to be distributed694/7€40k€36k▼
Return on contributions (dividend)694-€6k
Directors or managers695€40k€30k▼
The notes to these accounts (5 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.
Timeline · acts, filings and financial milestones
2025
31-08
NBB filing
Annual accounts filed
fiscal year 2024 · micro schema · 31 days late
2024
26-11
NBB filing
Annual accounts filed
fiscal year 2023 · micro schema · 118 days late
2023
31-12
Financial
Highest result since 2019net €56k ▲36.3%
Operating result €68k, net result €56k, both a record.
31-12
NBB filing
Annual accounts filed
fiscal year 2022 · micro schema · 153 days late
2022
31-12
NBB filing
Annual accounts filed
fiscal year 2021 · micro schema · 153 days late
2021
31-12
Financial
Back to profitnet €35k
Net result €35k after 2 loss-making years.
08-11
NBB filing
Annual accounts filed
fiscal year 2020 · micro schema · 100 days late
2020
02-10
NBB filing
Annual accounts filed
fiscal year 2019 · micro schema · 63 days late
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
Directors · office · real estate
Directors
3 acts for this company are in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Gembloux · 1 establishment unit since 2018
Cannot be placed on the map
This address could not be matched to a point in the Belgian address register (BOSA BEST). The address below comes straight from the Crossroads Bank.
Chaussée de Namur 3015030 GemblouxGround area
5,146 m²
Building footprint
152 m²
Parcel 92254A0387/00L000, Wallonia. Linked by address, not a title deed.
1 establishment unit
MEDIBLOUX
since 20182.282.640.721
1 parcel
Wallonia
1
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 92254A0387/00L000 | Wallonia | 5,146 m² | 1 · 152 m² | - |
Linked by address, not proof of ownership
Methodology
via registered seat: 1
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Similar companies · same sector, comparable size
DE PAREL ZORG EN DIENSTENCENTRUM
BE 0832.864.467
Herzele · Eq €37k
PROCURA
BE 0473.814.118
Stekene · Eq €37k
OrthoGreen Mobility
BE 0767.605.837
Sint-Jans-Molenbeek · Eq €37k
Orthopedic Services
BE 1005.311.661
Chastre · Eq €36k
MEDICAL PROCESSING TECHNOLOGIES INTERNATIONAL
BE 0478.461.210
Diepenbeek · Eq €36k
Of 1,064 companies in sector 47741 we hold annual accounts for 640. 395 are within a factor 10 of this equity.See the whole sector
Company data · Crossroads Bank
Identification
Legal formPrivate limited company (pre-2019)
Founded04-12-2018
Fiscal year end31-12
Activities, NACEBEL
47740Retail trade
47741Retail sale of medical and orthopaedic goods, excluding prescription glasses and lenses
47120Other non-specialised retail sale
47910Retail trade
53100Postal and courier activities
Sources
Crossroads Bank for EnterprisesNational Bank · 6 filingsAddress and cadastre registers
Data from official sources, last processed on 16-09-2026. Scores and ratios are computed by Checked and are not a credit decision.
Contact details
2 entriesE-mail:sandrine.ruth@gmail.com
Phone:+32473294020